Join
Live feed
·
INSIDERFilingvia Quantisnow
Seres Therapeutics Inc. logo

Officer Desrosier Thomas sold $373 worth of shares (82 units at $4.55) as part of a pre-agreed trading plan and converted options into 245 shares, increasing direct ownership by 2% to 8,117 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MCRB (Seres Therapeutics Inc.) and more on Quantisnow.